Activation of AKT predicts poor outcome in neuroblastoma

被引：0
|
作者：
Fulda, S.
Opel, D.
Poremba, C.
Simon, T.
Debatin, K. M.
Fulda, S.
机构：
[1] Univ Ulm, Childrens Hosp, Ulm, Germany
[2] Univ Dusseldorf, D-4000 Dusseldorf, Germany
[3] Univ Cologne, Cologne, Germany
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1413
引用
收藏
页码：506 / 506
页数：1
相关论文
共 50 条
  • [1] Activation of Akt predicts poor outcome in neuroblastoma
    Opel, Daniela
    Poremba, Christopher
    Simon, Thorsten
    Debatin, Klaus Michael
    Fulda, Simone
    CANCER RESEARCH, 2007, 67 (02) : 735 - 745
  • [2] ACTIVATION OF AKT BY HYPOXIA PREDICTS POOR OUTCOME IN MALIGNANT PLEURAL MESOTHELIOMA (MPM)
    Gately, K. A.
    Stewart, D.
    Heavey, S.
    Davies, A.
    O'Byrne, K. J.
    ANNALS OF ONCOLOGY, 2012, 23 : 78 - 78
  • [3] AKT activation predicts outcome in breast cancer patients treated with tamoxifen
    Kirkegaard, T
    Witton, CJ
    McGlynn, LM
    Tovey, SM
    Dunne, B
    Lyon, A
    Bartlett, JMS
    JOURNAL OF PATHOLOGY, 2005, 207 (02): : 139 - 146
  • [4] Expression of CD133 and poor outcome in neuroblastoma associated with chemoresistance mediated by AKT pathway
    Sartelet, H.
    Haddad, E.
    Imbriglio, T.
    Arsenault, M.
    Ohta, S.
    Barrette, S.
    Sinnett, D.
    Laverdiere, C.
    Oligny, L.
    Vassal, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway
    Sartelet, Herve
    Imbriglio, Tina
    Nyalendo, Carine
    Haddad, Elie
    Annabi, Borhane
    Duval, Michel
    Fetni, Raouf
    Victor, Kokta
    Alexendrov, Lubo
    Sinnett, Daniel
    Fabre, Monique
    Vassal, Gilles
    HISTOPATHOLOGY, 2012, 60 (07) : 1144 - 1155
  • [6] Phosphorylation of akt (Ser473) predicts poor clinical outcome in oropharyngeal squamous cell cancer
    Yu, Ziwei
    Weinberger, Paul M.
    Sasaki, Clarence
    Egleston, Brian L.
    Speier, William F.
    Haffty, Bruce
    Kowalski, Diane
    Camp, Robert
    Rimm, David
    Vairaktaris, Eleftherios
    Burtness, Barbara
    Psyrri, Amanda
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (03) : 553 - 558
  • [7] Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients
    G Pérez-Tenorio
    O Stål
    British Journal of Cancer, 2002, 86 : 540 - 545
  • [8] Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients
    Pérez-Tenorio, G
    Stål, O
    BRITISH JOURNAL OF CANCER, 2002, 86 (04) : 540 - 545
  • [9] TISSUE FACTOR EXPRESSION PREDICTS OUTCOME IN CHILDREN WITH NEUROBLASTOMA
    Sherief, L.
    Hasan, T.
    Marwa, B.
    Elia, E.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 193 - 193
  • [10] TISSUE FACTOR EXPRESSION PREDICTS OUTCOME IN CHILDREN WITH NEUROBLASTOMA
    Hassan, T.
    Sherief, L.
    Eshak, E.
    Bebars, M.
    HAEMATOLOGICA, 2012, 97 : 194 - 194
12345